These stocks pay between 4.2% and 6.7% in dividends.

Whichever one you choose, you'll need patience before you can see solid returns.

The smart money on Pfizer (NYSE: PFE) is sending a quieter signal than the financial press typically rewards: institutional ...

Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...

PFE yields 6.58% at a forward P/E of 9, while MRK surged 61% over the past year with a far smaller payout. KEYTRUDA drives roughly half of Merck's pharma revenue, making its biosimilar patent cliff ...

Pfizer is an over-100-year-old drug company going through a rough patch, which has happened before.

AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies ...

Can a push into oncology and next-generation therapies make up for Pfizer's post-Covid letdown?

Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer yesterday. The company’s shares closed yesterday at $25.63. Claim 55% Off TipRanks. Unlock trusted, data-back ...